Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maxillary Sinus Carcinoma”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableStudy completedNCT06865313
What this trial is testing

Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction

Who this might be right for
Maxillary Sinus Squamous Cell Carcinoma
Hôpital de la Croix-Rousse 16
Testing effectiveness (Phase 2)Looking for participantsNCT04870762
What this trial is testing

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Who this might be right for
Head and Neck CarcinomaMalignant Parotid Gland NeoplasmMaxillary Sinus Carcinoma+4 more
M.D. Anderson Cancer Center 119
Not applicableStudy completedNCT04788264
What this trial is testing

Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment

Who this might be right for
Head and Neck CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+13 more
Thomas Jefferson University 12
Early research (Phase 1)Looking for participantsNCT05172245
What this trial is testing

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Carcinoma of Unknown PrimaryLocally Advanced Head and Neck Squamous Cell Carcinoma+23 more
National Cancer Institute (NCI) 46